The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.

Part of paid clinical trials in Buffalo, New York.

Sponsor
Jacobs institute
Study ID
NCT07761598
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Aneurysm Cerebral

Eligibility Criteria

Sex
ALL
Age
22 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Fred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy. — DEVICE
    medial device intervention for aneurysm cerebral.

Study Details

The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.

Key Dates

First listed
Aug 12, 2026
Start date
Aug 31, 2026
Status verified
Aug 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Single arm study for a medical device for the FREDX device for aneurysm cerebral treatment with DAPT

Primary Outcome Measure

A thromboembolic event in the territory supplied by the treated artery. [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The Jacobs InstituteBuffaloNew York14203
Carlos Dr. Pena, PhD
[email protected]
(716) 888-4814
Kevin MacDonald
[email protected]
(716) 888-4814

Find similar trials in Buffalo, NY

By research site
The Jacobs Institute· Buffalo, NY

Related Studies